Method for determining the concentration of intact microorganisms in a sample
The present invention relates to a method of determining the concentration of intact microorganisms in a sample comprising optionally diluting an aliquot of the sample to provide a diluted aliquot at a dilution value; contacting at least a portion of an aliquot or of a diluted aliquot of the sample with first and second stains capable of binding to DNA, wherein the first stain is a fluorescent stain, is cell-permeable, and has a first emission wavelength, and the second stain is cell-impermeable, and is capable of acting as an acceptor molecule in a FRET pair with the first stain acting as a donor molecule; imaging the aliquot-stain mixture at the first emission wavelength and determining an image analysis value for the number of objects corresponding to intact microorganisms in the imaged mixture; and comparing the image analysis value for said aliquot to a pre-determined calibration curve, as well as an apparatus, a consumable and a kit therefor.
1. A method of determining the concentration of intact microorganisms in a sample derived from a sample containing microbial and non-microbial cells, said method comprising:
(a) providing a sample containing microorganisms, wherein non-microbial cells in a sample containing microbial and non-microbial cells have been selectively lysed, or wherein non-microbial cells in a sample containing microbial and non-microbial cells have been selectively lysed and microbial cells have been recovered therefrom;
(b) optionally diluting an aliquot of said sample to provide a diluted aliquot at a dilution value;
(c) contacting at least a portion of an aliquot of the sample of step (a), or of a diluted aliquot of the sample either during or after dilution step (b), with first and second stains capable of binding to DNA to provide a sample-stain mixture, wherein said first stain is a fluorescent stain, is cell-permeable, and has a first emission wavelength, said second stain is cell-impermeable, and is capable of acting as an acceptor molecule in a FRET pair with the first stain acting as a donor molecule and has a higher DNA binding affinity than the first stain, such that the second stain is able to displace the first stain from DNA;
(d) imaging the aliquot-stain mixture of step (c) at the first emission wavelength and determining an image analysis value for the number of objects corresponding to intact microorganisms in the imaged mixture, wherein said imaging is performed on a suspension of microorganisms; and
(e) comparing the image analysis value for said aliquot to a pre-determined calibration curve, thereby to determine the concentration of intact microorganisms in said sample.
2. The method of claim 1 , wherein:
(i) an aliquot of the sample is diluted to provide a diluted aliquot at a dilution value, wherein contacting step (c) takes place either during or after dilution step (b), and wherein steps (c)-(e) are performed on the diluted aliquot; and/or
(ii) wherein the method comprises diluting aliquots of said sample to provide two or more diluted aliquots at different dilution values, wherein said two or more aliquots are prepared simultaneously before or during step (c), or sequentially wherein a second or further diluted aliquot is prepared after steps (d) and/or (e); and/or
(iii) wherein steps (c) and (d) are performed on two or more aliquots at different dilution values, and wherein step (e) comprises identifying an aliquot which comprises an image analysis value within the range of a pre-determined calibration curve, and comparing the image analysis value for said aliquot to said pre-determined calibration curve, thereby to determine the concentration of viable microorganisms in said sample.
3. The method of claim 2 , wherein steps (c) and (d) are performed on each aliquot simultaneously, or wherein steps (c) and (d) are performed on each aliquot sequentially.
4. The method of claim 1 , wherein:
(i) when the non-microbial cells in the sample containing microbial and non-microbial cells have been selectively lysed in (a), said method does not comprise detecting the second stain; or
(ii) when the non-microbial cells in the sample containing microbial and non-microbial cells have been selectively lysed and microbial cells have been recovered therefrom in (a), said method comprises detecting the second stain.
5. The method of claim 4 , wherein when the non-microbial cells in the sample containing microbial and non-microbial cells have been selectively lysed and microbial cells have been recovered therefrom, step (d) comprises simultaneously imaging each aliquot-stain mixture to detect the first and second stains.
6. The method of claim 1 , wherein the sample comprises microorganisms contained in a growth medium.
7. The method of claim 1 , wherein the first and second stains are pre-mixed to form a stain solution, prior to contacting the aliquot of the sample or diluted aliquot of the sample, or portion thereof, in step (c).
8. The method of claim 1 , wherein:
(i) the fluorescence intensity of said first fluorescent stain at said first emission wavelength is enhanced when the stain is bound to nucleic acid; and/or
(ii) said first fluorescent stain has excitation and emission wavelengths in the wavelength range 350-700 nm; and/or
(iii) said first fluorescent stain is a green-fluorescent stain; and/or
(iv) said first fluorescent stain is an unsymmetrical cyanine dye; and/or
(v) the first fluorescent stain is a SYTO stain; and/or
(vi) the first fluorescent stain is SYTO BC; and/or
(vii) the second stain is a fluorescent stain; and/or
(viii) the second stain is a red-fluorescent stain; and/or
(ix) the red-fluorescent stain is propidium iodide.
9. The method of claim 1 , wherein:
(i) an image is obtained at one or more focal planes through the suspension; or
(ii) said imaging comprises obtaining a series of 2-D images along an optical axis,
wherein each image is obtained at a different position along the optical axis through a volume of the suspension.
10. The method of claim 9 , wherein:
(i) step (c) of contacting with the stains is performed at a temperature of greater than 4° C.; and/or
(ii) in the contacting of step (c) the aliquot or diluted aliquot, or portion thereof, is incubated with the first and second stains for a time period of 1 to 20 minutes; and/or
(iii) the imaging in step (d) is carried out at room temperature; and/or
(iv) in the imaging step (d) it is identified whether the microorganisms are clustering or non-clustering and a calibration curve is used which is predetermined for clustering or non-clustering microorganisms; and/or
(v) the images are analysed for fluorescence intensity and/or size of each enumerated object, and optionally morphology of each enumerated object; and/or
(vi) the images are analysed for maximum fluorescence intensity, median fluorescence intensity and/or area of each enumerated object; and/or
(vii) the images are analysed for maximum, median and/or mean fluorescence intensity and/or area of the population of objects; and/or
(viii) the concentration of viable microorganisms is determined.
11. A method for determining the antimicrobial susceptibility of a microorganism in a sample, said method comprising:
(i) providing a sample containing a viable microorganism wherein (i) non-microbial cells in a sample containing microbial and non-microbial cells have been selectively lysed, or wherein (ii) non-microbial cells in a sample containing microbial and non-microbial cells have been selectively lysed and microbial cells have been recovered therefrom;
(ii) performing steps (b)-(e) as defined in claim 1 on said sample to determine the concentration of intact microbial cells in said sample;
(iii) inoculating a series of test microbial cultures for an antibiotic susceptibility test (AST) using the sample in step (i), wherein the series of test microbial cultures comprises at least two different growth conditions, wherein the different growth conditions comprise one or more different antimicrobial agents, and each antimicrobial agent is tested at two or more different concentrations; and
(iv) assessing the degree of microbial growth in each growth condition;
wherein the concentration of microbial cells in said sample or said test microbial cultures is adjusted if necessary to a desired or pre-determined concentration; and
wherein the degree of microbial growth in each growth condition is used to determine at least one MIC value for at least one antimicrobial agent, thereby to determine the antimicrobial susceptibility of said microorganism in said sample.
12. The method of claim 11 , wherein:
(i) based on the concentration determined in step (ii), the concentration of at least a portion of the sample of step (i) is adjusted to provide an inoculum for inoculating the test microbial cultures in step (iii); and/or
(ii) the step of adjusting the concentration comprises a dilution based on the concentration determined in step (ii); and/or
(iii) following step (ii), at least a portion of the sample of step (i) is diluted to provide an inoculum for step (iii); and/or
(iv) wherein the concentration of microorganisms in the inoculated microbial test cultures is in the range 4.5×10 5 ±80% or 5×10 5 ±60%; and/or
(v) at least one of the test microbial cultures comprises fastidious medium; and/or
(vi) the concentration adjustment comprises culturing or further culturing the sample;
and/or
(vii) if the concentration of microorganisms in the sample is below 1×10 6 microorganisms, the AST assay is not performed with the sample.